BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21029970)

  • 1. Asymptomatic primary hyperparathyroidism--commentary on current management.
    Khan A
    J Clin Densitom; 2010; 13(4):321-3. PubMed ID: 21029970
    [No Abstract]   [Full Text] [Related]  

  • 2. AME position statement: primary hyperparathyroidism in clinical practice.
    Zini M; Attanasio R; Cesareo R; Emmolo I; Frasoldati A; Gianotti L; Guglielmi R; Piovesan A; Procopio M; Scillitani A; Versari A; Bollerslev J; Rao DS; Marcocci C; Borretta G;
    J Endocrinol Invest; 2012 Jul; 35(7 Suppl):2-21. PubMed ID: 22824948
    [No Abstract]   [Full Text] [Related]  

  • 3. Current treatments in the management of patients with primary hyperparathyroidism.
    Iglesias P; Díez JJ
    Postgrad Med J; 2009 Jan; 85(999):15-23. PubMed ID: 19240283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperparathyroidism and the role of the nurse.
    Walker J
    Nurs Older People; 2016 Jul; 28(6):27-32. PubMed ID: 27353790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When would I use medical therapies for the treatment of primary hyperparathyroidism?
    Crowley RK; Gittoes NJ
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):770-3. PubMed ID: 24111629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing primary hyperparathyroidism in primary care.
    Drug Ther Bull; 2010 Mar; 48(3):30-3. PubMed ID: 20200146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
    BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study.
    Lumachi F; Camozzi V; Ermani M; DE Lotto F; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():357-61. PubMed ID: 17646261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperparathyroidism: an update.
    Habib Z; Camacho P
    Curr Opin Endocrinol Diabetes Obes; 2010 Dec; 17(6):554-60. PubMed ID: 20890202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical example of conservative management of a female patient with manifestation of primary hyperparathyroidism].
    Mokrysheva HG; Peretokina EV; Rozhinskaia LIa
    Ter Arkh; 2014; 86(8):99-101. PubMed ID: 25306753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperparathyroidism.
    Kelly KJ; Chen H; Sippel RS
    Cancer Treat Res; 2010; 153():87-103. PubMed ID: 19957221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Primary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2010 May; 20(5):728-34. PubMed ID: 20445284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M;
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parathyroid and bone. Skeletal derangement in patients with primary hyperparathyroidism].
    Takeuchi Y
    Clin Calcium; 2007 Dec; 17(12):1815-21. PubMed ID: 18057655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperparathyroidism: management after unsuccessful parathyroid surgery.
    Silverberg SJ
    Br J Surg; 2021 Dec; 108(12):1400-1401. PubMed ID: 34738097
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsurgical management of primary hyperparathyroidism.
    Farford B; Presutti RJ; Moraghan TJ
    Mayo Clin Proc; 2007 Mar; 82(3):351-5. PubMed ID: 17352371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate.
    Gurevich Y; Poretsky L
    Otolaryngol Head Neck Surg; 2008 Mar; 138(3):403-4. PubMed ID: 18312894
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone status after parathyroidectomy for primary hyperparathyroidism].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2005 Dec; 15(12):11-16. PubMed ID: 16322668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.